Acknowledgement
This work was supported by the Dong-A University research fund.
References
- Korea Central Cancer Registry, National Cancer Center. Annual report of cancer statistics in Korea in 2018. Sejong: Ministry of Health and Welfare 2020
- Ark JT, Keegan KA, Barocas DA, Morgan TM, Resnick MJ, You C, et al. Incidence and predictors of understaging in patients with clinical T1 urothelial carcinoma undergoing radical cystectomy. BJU Int 2014;113:894-899 https://doi.org/10.1111/bju.12245
- Verma S, Rajesh A, Prasad SR, Gaitonde K, Lall CG, Mouraviev V, et al. Urinary bladder cancer: role of MR imaging. Radiographics 2012;32:371-387 https://doi.org/10.1148/rg.322115125
- Browne RF, Meehan CP, Colville J, Power R, Torreggiani WC. Transitional cell carcinoma of the upper urinary tract: spectrum of imaging findings. Radiographics 2005;25:1609-1627 https://doi.org/10.1148/rg.256045517
- Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstrom PU, Choi W, et al. Bladder cancer. Lancet 2016;388:2796-2810 https://doi.org/10.1016/S0140-6736(16)30512-8
- Wolfman DJ, Marko J, Nikolaidis P, Khatri G, Dogra VS, Ganeshan D, et al. ACR appropriateness criteriaⓇ hematuria. J Am Coll Radiol 2020;17:S138-S147 https://doi.org/10.1016/j.jacr.2020.01.028
- Datta SN, Allen GM, Evans R, Vaughton KC, Lucas MG. Urinary tract ultrasonography in the evaluation of haematuria--a report of over 1,000 cases. Ann R Coll Surg Engl 2002;84:203-205
- Barocas DA, Boorjian SA, Alvarez RD, Downs TM, Gross CP, Hamilton BD, et al. Microhematuria: AUA/SUFU guideline. J Urol 2020;204:778-786 https://doi.org/10.1097/JU.0000000000001297
- Trinh TW, Glazer DI, Sadow CA, Sahni VA, Geller NL, Silverman SG. Bladder cancer diagnosis with CT urography: test characteristics and reasons for false-positive and false-negative results. Abdom Radiol (NY) 2018;43:663-671 https://doi.org/10.1007/s00261-017-1249-6
- Lee CH, Tan CH, Faria SC, Kundra V. Role of imaging in the local staging of urothelial carcinoma of the bladder. AJR Am J Roentgenol 2017;208:1193-1205 https://doi.org/10.2214/AJR.16.17114
- Helenius M, Brekkan E, Dahlman P, Lonnemark M, Magnusson A. Bladder cancer detection in patients with gross haematuria: computed tomography urography with enhancement-triggered scan versus flexible cystoscopy. Scand J Urol 2015;49:377-381 https://doi.org/10.3109/21681805.2015.1026937
- Mirmomen SM, Shinagare AB, Williams KE, Silverman SG, Malayeri AA. Preoperative imaging for locoregional staging of bladder cancer. Abdom Radiol (NY) 2019;44:3843-3857 https://doi.org/10.1007/s00261-019-02168-z
- Tekes A, Kamel I, Imam K, Szarf G, Schoenberg M, Nasir K, et al. Dynamic MRI of bladder cancer: evaluation of staging accuracy. AJR Am J Roentgenol 2005;184:121-127 https://doi.org/10.2214/ajr.184.1.01840121
- Pecoraro M, Takeuchi M, Vargas HA, Muglia VF, Cipollari S, Catalano C, et al. Overview of VI-RADS in bladder cancer. AJR Am J Roentgenol 2020;214:1259-1268 https://doi.org/10.2214/AJR.20.22763
- Cornelissen SWE, Veenboer PW, Wessels FJ, Meijer RP. Diagnostic accuracy of multiparametric MRI for local staging of bladder cancer: a systematic review and meta-analysis. Urology 2020;145:22-29 https://doi.org/10.1016/j.urology.2020.07.021
- Gandhi N, Krishna S, Booth CM, Breau RH, Flood TA, Morgan SC, et al. Diagnostic accuracy of magnetic resonance imaging for tumour staging of bladder cancer: systematic review and meta-analysis. BJU Int 2018;122:744-753 https://doi.org/10.1111/bju.14366
- Panebianco V, Narumi Y, Altun E, Bochner BH, Efstathiou JA, Hafeez S, et al. Multiparametric magnetic resonance imaging for bladder cancer: development of VI-RADS (Vesical Imaging-Reporting And Data System). Eur Urol 2018;74:294-306 https://doi.org/10.1016/j.eururo.2018.04.029
- Takeuchi M, Sasaki S, Ito M, Okada S, Takahashi S, Kawai T, et al. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade. Radiology 2009;251:112-121 https://doi.org/10.1148/radiol.2511080873
- de Haas RJ, Steyvers MJ, Futterer JJ. Multiparametric MRI of the bladder: ready for clinical routine? AJR Am J Roentgenol 2014;202:1187-1195 https://doi.org/10.2214/AJR.13.12294
- Panebianco V, Barchetti F, de Haas RJ, Pearson RA, Kennish SJ, Giannarini G, et al. Improving staging in bladder cancer: the increasing role of multiparametric magnetic resonance imaging. Eur Urol Focus 2016;2:113-121 https://doi.org/10.1016/j.euf.2016.04.010
- Kobayashi S, Koga F, Kajino K, Yoshita S, Ishii C, Tanaka H, et al. Apparent diffusion coefficient value reflects invasive and proliferative potential of bladder cancer. J Magn Reson Imaging 2014;39:172-178 https://doi.org/10.1002/jmri.24148
- Rosenkrantz AB, Obele C, Rusinek H, Balar AV, Huang WC, Deng FM, et al. Whole-lesion diffusion metrics for assessment of bladder cancer aggressiveness. Abdom Imaging 2015;40:327-332 https://doi.org/10.1007/s00261-014-0213-y
- Woo S, Suh CH, Kim SY, Cho JY, Kim SH. Diagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: a systematic review and meta-analysis. Eur J Radiol 2017;95:46-55 https://doi.org/10.1016/j.ejrad.2017.07.021
- Panebianco V, De Berardinis E, Barchetti G, Simone G, Leonardo C, Grompone MD, et al. An evaluation of morphological and functional multi-parametric MRI sequences in classifying non-muscle and muscle invasive bladder cancer. Eur Radiol 2017;27:3759-3766 https://doi.org/10.1007/s00330-017-4758-3
- Cumberbatch MGK, Foerster B, Catto JWF, Kamat AM, Kassouf W, Jubber I, et al. Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review. Eur Urol 2018;73:925-933 https://doi.org/10.1016/j.eururo.2018.02.014
- Herr HW. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 2005;174:2134-2137 https://doi.org/10.1097/01.ju.0000181799.81119.fc
- Wang HJ, Pui MH, Guo Y, Yang D, Pan BT, Zhou XH. Diffusion-weighted MRI in bladder carcinoma: the differentiation between tumor recurrence and benign changes after resection. Abdom Imaging 2014;39:135-141 https://doi.org/10.1007/s00261-013-0038-0
- Necchi A, Bandini M, Calareso G, Raggi D, Pederzoli F, Fare E, et al. Multiparametric magnetic resonance imaging as a noninvasive assessment of tumor response to neoadjuvant pembrolizumab in muscle-invasive bladder cancer: preliminary findings from the PURE-01 study. Eur Urol 2020;77:636-643 https://doi.org/10.1016/j.eururo.2019.12.016
- Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline. J Urol 2016;196:1021-1029 https://doi.org/10.1016/j.juro.2016.06.049
- Girard A, Vila Reyes H, Shaish H, Grellier JF, Dercle L, Salaun PY, et al. The role of 18F-FDG PET/CT in guiding precision medicine for invasive bladder carcinoma. Front Oncol 2020;10:565086
- Caglic I, Panebianco V, Vargas HA, Bura V, Woo S, Pecoraro M, et al. MRI of bladder cancer: local and nodal staging. J Magn Reson Imaging 2020;52:649-667 https://doi.org/10.1002/jmri.27090
- Rajesh A, Sokhi H, Fung R, Mulcahy KA, Bankart MJ. Role of whole-body staging computed tomographic scans for detecting distant metastases in patients with bladder cancer. J Comput Assist Tomogr 2011;35:402-405 https://doi.org/10.1097/RCT.0b013e318214ad58